Equitable Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
JSAM
AT
AWC
Equitable Holdings's PPH Position: Q2 2026 in Review
Equitable Holdings reduced its VanEck Pharmaceutical ETF (PPH) stake by 1.4% in Q2 2026, selling an estimated $20.1K and leaving 14,048 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #836.
Equitable Holdings first reported a position in PPH in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.3M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- Equitable Holdings held 14,048 shares of VanEck Pharmaceutical ETF worth $1.54M as of Q2 2026.
- Equitable Holdings sold 194 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $20.1K.
- VanEck Pharmaceutical ETF made up 0.01% of Equitable Holdings's portfolio in Q2 2026, its #836 holding.
- Equitable Holdings first reported a position in VanEck Pharmaceutical ETF in Q1 2022 and has held it in 18 quarters since.
- Equitable Holdings's VanEck Pharmaceutical ETF position peaked at $2.3M in Q3 2024.
- 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.